Stay updated on Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Recruitment status updated to 'no longer looking for participants' signals enrollment has ended. The page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label, along with a Revision: v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-10T17:57:33.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision updated from v3.5.4 to v3.5.5, indicating a new edition of the page metadata. There are no changes to the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-06-03T09:31:32.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    Publications section now lists the NEJM article by Murthy et al. on tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer with full author names and citation details. The previous NEJM entry that included an erratum has been removed.
    Difference
    0.0%
    Check dated 2026-05-20T06:48:22.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Added a new revision label v3.5.3 and removed the previous v3.5.2, indicating an updated release version on the page. This appears to be a meta-level update rather than a change to study details or content.
    Difference
    0.0%
    Check dated 2026-04-28T08:12:37.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page’s displayed revision version was updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-21T03:12:40.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Publication reference in the Publications section was updated: the NEJM 2020 Tucatinib paper is added and the prior NEJM citation is removed.
    Difference
    0.0%
    Check dated 2026-04-14T02:26:12.000Z thumbnail image

Stay in the know with updates to Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page.